title: KELH0021_P-19_48F26

status: Public on Jul 31 2007

city: Toronto

first: Mark

last: Cameron

state: Ontario

address: 3-913 TMDT, MaRS Centre, 101 College St.

institute: UHN

description: Peripheral blood was collected longitudinally from SARS patients during hospitalization into heparinized tubes and processed for further analysis within 2-3 hours of collection.  RNA was stabilized and purified using Paxgene Blood Collection Tubes and Paxgene RNA kits (Qiagen, Mississauga, ON, Canada).

hyb_protocol: similar to direct labelling protocol listed at UHN Microarray facility web site.

scan_protocol: Scanned at 16 bits using the Genepix Axon Scanner at 10micro-meter resolution at 635 nm (Cy5) and 532 nm (Cy3) using Genepix Pro 6.0 analysis software (Molecular Devices Corporation)

data_processing: Each quantified output file was run though the following pre-processing steps using R (URL: www.r-project.org)and the Limma package. For Minimum Intensity filtering, R and G values were treated with a surrogate replacement policy for estimating sub-threshold values. The raw merged R and G channels were lowess-normalized (grouped by print-tip), normalized between chips using quantile normalization and transformed to log2 ratios (70).

source_name: Universal RNA

label_protocol: Universal RNA probes was prepared by direct labeling of universal aRNA with Cy-3 fluorescent dye

extract_protocol: Universal human reference RNA was purchased from Stratagene and was amplified using MessageAMP aRNA kits (Ambion) as per manufacturer's instructions prior to labeling

tag: Tissue:Universal RNA

source_name: PBMC

label_protocol: Sample probes were prepared by direct labeling with Cy-5 fluorescent dye

extract_protocol: Total RNA was isolated using Paxgene blood collection tubes then amplified using the MessageAmp aRNA kit (Ambion) as per the manufacturer's instructions.

tag: Tissue:Blood, Patient id:P-19, Age:48, Sex:F, DSO:26, Status:pre-pO2 nadir


title: KELH0022_P-19_48F52

type: RNA

middle: J

country: Canada

molecule: total RNA

organism: Homo sapiens

tag: Tissue:Blood, Patient id:P-19, Age:48, Sex:F, DSO:52, Status:pre-pO2 nadir


title: KELH0058_P-45_43M5

tag: Tissue:Blood, Patient id:P-45, Age:43, Sex:M, DSO:5, Status:pre-pO2 nadir


title: KELH0005_P-5_46F7

tag: Tissue:Blood, Patient id:P-5, Age:46, Sex:F, DSO:7, Status:pre-pO2 nadir


title: KELH0043_P-33_52F18

tag: Tissue:Blood, Patient id:P-33, Age:52, Sex:F, DSO:18, Status:post-pO2 nadir


title: KELH0057_P-44_47F27

tag: Tissue:Blood, Patient id:P-44, Age:47, Sex:F, DSO:27, Status:convalescent


title: KELH0032_P-24_81F27

tag: Tissue:Blood, Patient id:P-24, Age:81, Sex:F, DSO:27, Status:pre-pO2 nadir


title: KELH0029_P-24_81F7

tag: Tissue:Blood, Patient id:P-24, Age:81, Sex:F, DSO:7, Status:post-pO2 nadir


title: KELH0018_P-19_48F8

tag: Tissue:Blood, Patient id:P-19, Age:48, Sex:F, DSO:8, Status:convalescent


title: KELH0003_P-3_34M2

tag: Tissue:Blood, Patient id:P-3, Age:34, Sex:M, DSO:2, Status:pre-pO2 nadir


title: KELH0007_P-7_50F8

tag: Tissue:Blood, Patient id:P-7, Age:50, Sex:F, DSO:8, Status:pre-pO2 nadir


title: KELH0041_P-32_62F2

tag: Tissue:Blood, Patient id:P-32, Age:62, Sex:F, DSO:2, Status:pre-pO2 nadir


title: KELH0038_P-30_83F7

tag: Tissue:Blood, Patient id:P-30, Age:83, Sex:F, DSO:7, Status:post-pO2 nadir


title: KELH0056_P-42_27F11

tag: Tissue:Blood, Patient id:P-42, Age:27, Sex:F, DSO:11, Status:post-pO2 nadir


title: KELH0016_P-16_35M21

tag: Tissue:Blood, Patient id:P-16, Age:35, Sex:M, DSO:21, Status:post-pO2 nadir


title: KELH0040_P-31_66F5

tag: Tissue:Blood, Patient id:P-31, Age:66, Sex:F, DSO:5, Status:pre-pO2 nadir


title: KELH0023_P-20_39F1

tag: Tissue:Universal RNA

tag: Tissue:Blood, Patient id:P-20, Age:39, Sex:F, DSO:1, Status:pre-pO2 nadir


title: KELH0036_P-27_42F34

tag: Tissue:Blood, Patient id:P-27, Age:42, Sex:F, DSO:34, Status:convalescent


title: KELH0047_P-34_63M10

tag: Tissue:Blood, Patient id:P-34, Age:63, Sex:M, DSO:10, Status:post-pO2 nadir


title: KELH0053_P-38_31F8

tag: Tissue:Blood, Patient id:P-38, Age:31, Sex:F, DSO:8, Status:pre-pO2 nadir


title: VDXRHU_5226

status: Public on Jun 11 2007

first: Benjamin

last: Haibe-Kains

address: 610 University Avenue

department: Princess Margaret Research

institute: Princess Margaret Cancer Centre

hyb_protocol: standard Affymetrix procedures.

scan_protocol: standard Affymetrix procedures.

data_processing: MAS5 Bioconductor (target value of 600).

label: biotin

label_protocol: Approximately 1 microgram of total RNA was processed to produce biotinylated cRNA targets.

extract_protocol: Isolation of RNA was performed using the Trizol method (Invitrogen) according to the manufacturers instructions and was purified using RNeasy mini-columns (Qiagen, Valencia, CA). The quality of the RNA obtained from each tumour sample was assessed based on the RNA profile generated by the bioanalyzer (Agilent Inc)olation of RNA was performed using the Trizol method (Invitrogen) according to the manufacturers instructions and was purified using RNeasy mini-columns (Qiagen, Valencia, CA). The quality of the RNA obtained from each tumour sample was assessed based on the RNA profile generated by the bioanalyzer (Agilent Inc).

tag: samplename

tag: id

tag: filename

tag: hospital

value: RH

tag: age

tag: size

tag: Histtype

tag: Angioinv

tag: node

tag: grade

tag: er

tag: risksg

tag: NPI

tag: risknpi

value: Poor


title: VDXRHU_5232


title: VDXRHU_5236

value: Good


title: VDXRHU_4188


title: VDXRHU_2039


title: VDXRHU_2587


title: VDXRHU_2320


title: VDXRHU_1917


title: VDXRHU_1745


title: VDXRHU_5235


title: VDXRHU_1970


title: VDXRHU_3642


title: VDXRHU_1767


title: VDXRHU_1720


title: VDXRHU_1919


title: VDXRHU_2393


title: VDXRHU_5228


title: VDXRHU_5223


title: VDXRHU_5240


title: VDXRHU_1771


title: VDXRHU_2248


title: VDXRHU_1721


title: VDXRHU_1549


title: VDXRHU_410


title: VDXRHU_302


title: VDXRHU_1568


title: VDXRHU_1315


title: VDXRHU_317


title: VDXRHU_1526


title: blood, Blood: 6000_0100_le1

status: Public on Jul 26 2007

city: Phoenix

first: Winnie

last: Liang

state: AZ

address: 445 N. Fifth Street

country: USA

institute: Translational Genomics

description: RNA from Lymphoblastoid Cell Line from this individual

source_name: blood, Blood


title: blood, Blood: 2285_0102_le1


title: blood, Blood: 2153_0103_le1


title: VDXRHU_1246


title: blood, Blood: 1442_0002_le1


title: VDXRHU_1522


title: VDXKIU_87A79

value: KAR


title: VDXRHU_1207


title: VDXRHU_1472


title: blood, Blood: 2391_0102_le1


title: VDXKIU_292C66


title: VDXKIU_284C63


title: blood, Blood: 1432_1203_le1


title: VDXKIU_268C87


title: VDXKIU_28C76


title: VDXKIU_282C51


title: VDXKIU_219C42


title: VDXKIU_279C61


title: VDXKIU_220C70


title: VDXRHU_535


title: blood, Blood: 2134_0122_le1


title: VDXKIU_15C5


title: VDXKIU_231C80


title: VDXRHU_1496


title: VDXKIU_16C8


title: VDXKIU_199B55


title: VDXKIU_27B8


title: VDXKIU_27D5


title: VDXKIU_15D6


title: blood, Blood: 2307_0001_le1


title: VDXKIU_144B49


title: VDXKIU_15H4


title: VDXKIU_43C47


title: VDXKIU_248C91


title: VDXKIU_15E7


title: VDXKIU_197B95


title: VDXKIU_2656


title: VDXKIU_15E8


title: VDXKIU_2743


title: blood, Blood: 2253_0103_le1


title: VDXKIU_15H3


title: VDXKIU_1246


title: VDXKIU_309C49


title: blood, Blood: 1577_0101_le1


title: VDXKIU_1000


title: VDXKIU_15E6


title: VDXOXFU_1210

value: JRH


title: VDXOXFU_1373


title: VDXKIU_16G1


title: VDXKIU_136B04


title: VDXKIU_15E2


title: VDXKIU_2889


title: VDXKIU_101B88


title: VDXKIU_15D7


title: VDXKIU_3367


title: VDXKIU_247C76


title: VDXKIU_27C4


title: VDXKIU_121


title: VDXOXFU_547


title: VDXKIU_1708


title: VDXOXFU_1006


title: VDXOXFU_513


title: VDXKIU_386


title: VDXOXFU_320


title: VDXOXFU_366


title: VDXKIU_2481


title: VDXKIU_440


title: VDXOXFU_194


title: VDXOXFU_104


title: VDXIGRU_307829

value: IGR


title: VDXOXFU_662


title: VDXIGRU_280775


title: VDXIGRU_307327


title: VDXOXFU_1065


title: VDXOXFU_530


title: VDXOXFU_245


title: VDXOXFU_220


title: VDXOXFU_1328


title: VDXIGRU_314827


title: VDXOXFU_37


title: VDXOXFU_360


title: VDXIGRU_271448


title: VDXIGRU_280328


title: VDXOXFU_157


title: VDXIGRU_271982


title: VDXIGRU_255627


title: VDXKIU_125B43


title: VDXKIU_15D9


title: VDXKIU_2946


title: VDXKIU_1608


title: VDXKIU_205


title: VDXIGRU_307506


title: VDXOXFU_1183


title: VDXIGRU_306818


title: VDXOXFU_544


title: VDXOXFU_57


title: VDXIGRU_272219


title: VDXIGRU_256209


title: VDXIGRU_307251


title: VDXOXFU_316


title: VDXIGRU_272823


title: VDXIGRU_256940


title: VDXIGRU_256975


title: VDXIGRU_246560


title: VDXIGRU_256734


title: VDXIGRU_247401


title: VDXIGRU_246381


title: VDXIGRU_219873


title: VDXIGRU_219863


title: VDXIGRU_171620


title: VDXIGRU_217320


title: VDXIGRU_247243


title: VDXIGRU_245596


title: VDXIGRU_246919


title: VDXIGRU_219468


title: VDXIGRU_219139


title: VDXIGRU_172086


title: VDXIGRU_254485


title: VDXIGRU_246821


title: VDXIGRU_245392


title: VDXIGRU_171260


title: VDXIGRU_246166


title: VDXIGRU_216806


title: VDXIGRU_216939


title: VDXIGRU_219587


title: VDXIGRU_246047


title: VDXIGRU_171558


title: VDXGUYU_4105

value: GUY


title: VDXIGRU_166154


title: VDXIGRU_247000


title: VDXIGRU_214603


title: VDXGUYU_4097


title: VDXGUYU_4060


title: VDXGUYU_4088


title: VDXGUYU_4074


title: VDXGUYU_4076


title: VDXIGRU_219490


title: VDXGUYU_4096


title: VDXIGRU_171150


title: VDXGUYU_4072


title: VDXGUYU_4062


title: VDXGUYU_4049


title: VDXGUYU_4099


title: VDXGUYU_4081


title: VDXGUYU_4054


title: VDXIGRU_211980


title: VDXGUYU_4045


title: VDXGUYU_4061


title: VDXGUYU_4075


title: VDXGUYU_4036


title: VDXGUYU_4046


title: VDXGUYU_4067


title: VDXGUYU_4098


title: VDXGUYU_4073


title: VDXGUYU_4056


title: VDXGUYU_4044


title: VDXGUYU_4087


title: VDXGUYU_4033


title: VDXGUYU_4052


title: VDXGUYU_4043


title: VDXGUYU_4041


title: VDXGUYU_4014


title: VDXGUYU_4034


title: VDXGUYU_4040


title: VDXGUYU_4002


title: VDXGUYU_4011


title: VDXGUYU_4022


title: VDXGUYU_4008


title: spinal cord, ventral spinal cord: EP144/L - G93R(Roth)/e14-mutant hSOD1_le2

status: Public on Apr 11 2007

description: mutant SOD1 - biological replicate 4/pool of 5 positive embryos

organism: Rattus norvegicus

source_name: spinal cord, ventral spinal cord


title: spinal cord, ventral spinal cord: EP 151/L - SDneg e14

description: negative control SOD1 pool of 5 positive embryos


title: spinal cord, ventral spinal cord: EP141/L - G93R(Roth)/e14-mutant hSOD1

description: mutant SOD1 - biological replicate 1/pool of 5 positive embryos


title: spinal cord, ventral spinal cord: EP131/L - hSOD1(Chan)/e14-wildtype hSOD1

description: wildtype SOD1 - biological replicate 1/pool of 5 positive embryos


title: spinal cord, ventral spinal cord: EP142/L - G93R(Roth)/e14-mutant hSOD1_le2

description: mutant SOD1 - biological replicate 2/pool of 5 positive embryos


title: spinal cord, ventral spinal cord: EP134/L - hSOD1(Chan)/e14-wildtype hSOD1_le2

description: wildtype SOD1 - biological replicate 4/pool of 5 positive embryos


title: spinal cord, ventral spinal cord: EP143/L - G93R(Roth)/e14-mutant hSOD1_le2

description: mutant SOD1 - biological replicate 3/pool of 5 positive embryos


title: spinal cord, ventral spinal cord: EP133/L - hSOD1(Chan)/e14-wildtype hSOD1_le2

description: wildtype SOD1 - biological replicate 3/pool of 5 positive embryos


title: whole animal, nucleus accumbens: Extract1_le1

status: Public on Mar 23 2007

description:
RNAi of Ce-imp-2 gene
Treatment, type=grow, description=Feed by  E.coli strain HT115 producing dsRNA for C.elegans imp-2 gene.

organism: Caenorhabditis elegans

source_name: whole animal, nucleus accumbens


title: liver, Whole tissue: Female D1_le1

status: Public on Mar 20 2007

description:
pool of 4 female livers
Treatment, type=harvest

organism: Gallus gallus

source_name: liver, Whole tissue


title: liver, Whole tissue: Female E1_le1


title: whole animal, nucleus accumbens: Extract-Control_le1

description:
RNAi of GFP gene
Treatment, type=grow, description=Feed by  E.coli strain HT115 producing dsRNA for GFP gene.


title: liver, Whole tissue: Female B1_le1


title: liver, Whole tissue: Male D1_le1

description:
pool of 4 male livers
Treatment, type=harvest


title: liver, Whole tissue: Female A1_le1


title: spinal cord, ventral spinal cord: EP132/L - hSOD1(Chan)/e14-wildtype hSOD1_le2

description: wildtype SOD1 - biological replicate 2/pool of 5 positive embryos


title: liver, Whole tissue: Female C1_le1


title: brain, Whole brain: Male B_e1_le1

description:
male sample
Treatment, type=dissect

source_name: brain, Whole brain


title: liver, Whole tissue: Male E1_le1


title: brain, Whole brain: Male E_e1_le1

description:
male sample
Treatment, type=dissect


title: liver, Whole tissue: Male B1_le1


title: liver, Whole tissue: Male A1_le1


title: heart, Whole tissue: Female EH_le1

description:
pool of female heart RNAs
Treatment, type=harvest

source_name: heart, Whole tissue


title: heart, Whole tissue: Male DH_le1

description:
pool of males
Treatment, type=harvest


title: heart, Whole tissue: Male EH_le1

description:
pool of males
Treatment, type=harvest


title: heart, Whole tissue: Female DH_le1

description:
pool of female biosource heart RNAs
Treatment, type=harvest


title: brain, hippocampus: Ketone bodies 6 hours #2_e1_le1

description:
RNA from hippocampal neurons treated with ketone bodies for 6 hours
Treatment, type=pharmacogenomic_treatment

source_name: brain, hippocampus


title: brain, Whole brain: Female A_e1_le1

description:
female sample
Treatment, type=dissect


title: brain, Whole brain: Female C_e1_le1

description:
female sample
Treatment, type=dissect


title: brain, Whole brain: Male D_e1_le1

description:
male sample
Treatment, type=dissect


title: brain, hippocampus: Ketone bodies 6 hours #1_e1_le1


title: brain, Whole brain: Female B_e1_le1

description:
female sample
Treatment, type=dissect


title: brain, Whole brain: Female D_e1_le1

description:
female sample
Treatment, type=dissect


title: brain, Whole brain: Male C_e1_le1

description:
male sample
Treatment, type=dissect


title: brain, Whole brain: Female E_e1_le1

description:
female sample
Treatment, type=dissect


title: brain, Whole brain: total RNA_le1

description:
male sample
Treatment, type=dissect


title: heart, Whole tissue: Female CH_le1


title: brain, hippocampus: Ketone bodies 6 hours #3_e1_le1


title: brain, hippocampus: Ketone bodies 1 hour #3_e1_le1

description:
RNA from hippocampal neurons treated with ketone bodies for 1 hour
Treatment, type=pharmacogenomic_treatment


title: brain, hippocampus: Ketone bodies 1 hour #2_e1_le1


title: brain, hippocampus: Control #3_e1_le1

description: RNA from hippocampal neurons exposed to artificial cerebospinal fluid only


title: brain, hippocampus: Control #2_e1_le1


title: heart, Whole tissue: Male BH_le1

description:
pool of males
Treatment, type=harvest


title: heart, Whole tissue: Male AH_le1

description:
pool of males
Treatment, type=harvest


title: heart, Whole tissue: male CH_le1

description:
pool of males
Treatment, type=harvest


title: heart, Whole tissue: Female BH_le1


title: heart, Whole tissue: Female AH_le1


title: brain, hippocampus: Ketone bodies 1 hour #1_e1_le1


title: brain, hippocampus: Control #1_e1_le1


title: KIU_38C94 (HG-U133A)

status: Public on Mar 01 2007

description: Tumor samples from untreated primary breast cancer patients.

hyb_protocol: standard Affymetrix procedures

scan_protocol: standard Affymetrix procedures

data_processing: RMA Bioconductor

source_name: breast

extract_protocol: Isolation of RNA was performed using the Trizol method (Invitrogen) according to the manufacturers instructions and was purified using RNeasy mini-columns (Qiagen, Valencia, CA). The quality of the RNA obtained from each tumour sample was assessed based on the RNA profile generated by the bioanalyzer (Agilent Inc)olation of RNA was performed using the Trizol method (Invitrogen) according to the manufacturers instructions and was purified using RNeasy mini-columns (Qiagen, Valencia, CA). The quality of the RNA obtained from each tumour sample was assessed based on the RNA profile generated by the bioanalyzer (Agilent Inc)

tag: ID

tag: series

value: KIU

tag: pgr


title: KIU_214C35 (HG-U133A)

tag: samplename


title: OXFU_446 (HG-U133A)

value: OXFU


title: OXFU_23 (HG-U133A)


title: KIU_219C42 (HG-U133A)


title: OXFU_471 (HG-U133A)


title: KIU_125B43 (HG-U133A)


title: TGF-beta2 TM 1a_e1_le1

status: Public on Feb 28 2007

description:
Human Trabecular Meshwork
Treatment, type=pharmacogenomic_treatment, description=Cells were treated with TGF-beta2.  Ages of pool were 16, 66,67,73,76.

source_name: Human Trabecular Meshwork


title: OXFU_489 (HG-U133A)


title: OXFU_359 (HG-U133A)


title: TGFbeta-2 TM 1b_e1_le1


title: TGF-beta1 TM 1a_e1_le1

description:
Human Trabecular Meshwork
Treatment, type=pharmacogenomic_treatment, description=Cells were treated with TGF-beta1.  Ages of pool were 16, 66,67,73,76.


title: Ctr TM 2b_e1_le1

description:
Human Trabecular Meshwork
Treatment, type=pharmacogenomic_treatment, description=Control cells were treated with EtOH.  Ages of pool were 16, 66,67,73,76.


title: OXFU_337 (HG-U133A)


title: TGF-beta1 TM 1b_e1_le1


title: Ctr TM 2a_e1_le1


title: OXFU_485 (HG-U133A)


title: DMD skeletal muscle, biological rep12

status: Public on Dec 25 2006

city: rotterdam

first: Mario

last: Pescatori

address: Westplein 11

country: Netherlands

institute: Health e-genomics

description: Gene expression data from skeletal muscle tissue of presymptomatic DMD children and age matched controls

hyb_protocol: Following fragmentation, 10 microg of cRNA were hybridized for 16 hr at 45C on HG 133A  Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.

data_processing: The data were analyzed with BRB-Array Tools using rma as probeset summarization algoritm

source_name: quadriceps muscle tissue of presymptomatic DMD children

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions. Tot RNA was further purified using the RNAeasy mini purification kit (QIAGEN) according to the RNA cleanup protocol

treatment_protocol: Muscle biopsies were flash frozen in liquid nitrogen and stored at -80°C until usage. Samples were homogenized using an IKA ultra-turrax T8 homogenizer

tag: sex

value: Male

tag: Age

value: 12 months

tag: additional patient information found in Series supplementary file


title: DMD skeletal muscle, biological rep7

value: 6 months


title: OXFU_885 (HG-U133A)

tag: age


title: DMD skeletal muscle, biological rep17

value: 20 months


title: DMD skeletal muscle, biological rep11

value: 11 months


title: DMD skeletal muscle, biological rep20

value: 28 months


title: DMD skeletal muscle, biological rep21

value: 47 months


title: DMD skeletal muscle, biological rep9

value: 8 months


title: DMD skeletal muscle, biological rep10


title: DMD skeletal muscle, technical rep1

value: 3 months


title: DMD skeletal muscle, biological rep15

value: 14 months


title: DMD skeletal muscle, biological rep4

value: 5 months


title: DMD skeletal muscle, biological rep16

value: 15 months


title: normal skeletal muscle, biological rep14

source_name: quadriceps muscle tissue of normal controls

value: 108 months


title: DMD skeletal muscle, biological rep22

value: 61 months


title: DMD skeletal muscle, biological rep13


title: DMD skeletal muscle, biological rep19

value: 22 months


title: DMD skeletal muscle, biological rep14


title: DMD skeletal muscle, biological rep5


title: DMD skeletal muscle, biological rep6


title: DMD skeletal muscle, biological rep18


title: normal skeletal muscle, biological rep3

value: Female


title: normal skeletal muscle, biological rep7


title: DMD skeletal muscle, biological rep2

value: 2.5 months


title: normal skeletal muscle, biological rep9

value: Male

value: 18 months


title: DMD skeletal muscle, biological rep8

value: 7 months


title: normal skeletal muscle, biological rep12

value: 50 months


title: normal skeletal muscle, biological rep13

value: 60 months


title: normal skeletal muscle, biological rep8

value: 11 months


title: normal skeletal muscle, biological rep2

value: 6 months


title: normal skeletal muscle, biological rep6


title: normal skeletal muscle, biological rep4


title: normal skeletal muscle, biological rep1


title: normal skeletal muscle, biological rep10

value: 33 months


title: DMD skeletal muscle, biological rep1

value: 1.5 months


title: DMD skeletal muscle, biological rep3

value: 3 months


title: normal skeletal muscle, biological rep11

value: 36 months


title: normal skeletal muscle, biological rep5


title: brain, cerebellum: Lh+/+_Crb2_e1_le1

status: Public on Nov 14 2006

description:
Total RNA extracted from the cerebellum of a Lh+/+ mutant mouse
Treatment, type=sacrifice

organism: Mus musculus

source_name: brain, cerebellum


title: brain, forebrain: Sample15_e1_le1

description:
Total RNA extracted from the forebrain of a Tg+/+ mutant mouse
Treatment, type=sacrifice

source_name: brain, forebrain


title: brain, cerebellum: Tg+/+_Crb1_e1_le1

description:
Total RNA extracted from the cerebellum of a Tg+/+ mutant mouse
Treatment, type=sacrifice


title: brain, adrenal medulla: 1A_e1_le1

status: Public on Jun 07 2006

description:
undigested
Treatment, type=time_course, measurement=1.0 d

source_name: brain, adrenal medulla


title: brain, cerebellum: Lh+/+_Crb1_e1_le1


title: brain, adrenal medulla: 1C_e1_le1

description:
digested
Treatment, type=time_course, measurement=1.0 d


title: brain, adrenal medulla: 7C_e1_le1

description:
digested
Treatment, type=time_course, measurement=7.0 d


title: brain, forebrain: Sample18_e1_le1

description:
Total RNA extracted from the forebrain of a Lh+/+ mutant mouse
Treatment, type=sacrifice


title: brain, forebrain: Sample13_e1_le1


title: brain, cerebellum: Stg+/+_Crb2_e1_le1

description:
Total RNA extracted from the cerebellum of a stg+/+ mutant mouse
Treatment, type=sacrifice


title: brain, adrenal medulla: 7A_e1_le1

description:
undigested
Treatment, type=time_course, measurement=7.0 d


title: brain, cerebellum: Stg+/+_Crb1_e1_le1


title: brain, cerebellum: Tg+/+_Crb3_e1_le1


title: brain, cerebellum: Stg+/+_Crb3_e1_le1


title: brain, forebrain: Sample14_e1_le1

description:
Total RNA extracted from the forebrain of a Tg+/+  mutant mouse
Treatment, type=sacrifice


title: brain, forebrain: Sample10_e1_le1

description:
Total RNA extracted from the forebrain of a Stg+/+  mutant mouse
Treatment, type=sacrifice


title: brain, forebrain: Sample12_e1_le1


title: brain, cerebellum: Lh+/+_Crb3_e1_le1


title: brain, forebrain: Sample11_e1_le1


title: brain, forebrain: Sample16_e1_le1


title: brain, forebrain: Sample17_e1_le1


title: brain, cerebellum: Tg+/+_Crb2_e1_le1


title: Multiple Organs, adrenal medulla: Cold-1-day-a_le1

status: Public on Jun 09 2006

description:
Rats were exposed to cold stress for one day
Treatment, type=time_course, measurement=1.0 d
Treatment, type=time_course, measurement=1.0 d

source_name: Multiple Organs, adrenal medulla


title: Multiple Organs, adrenal medulla: Cold-7-day-a_le1

description:
Rats were exposed in cold for 7 days
Treatment, type=time_course, measurement=7.0 d


title: Multiple Organs, adrenal medulla: Cold-1-day-b_le1

description:
rats were in cold for 1 day
Treatment, type=time_course, measurement=1.0 d


title: brain, frontal cortex: pADX PM DR b_e1_le1

status: Public on Jun 06 2006

description: Dorsal Raphe

source_name: brain, frontal cortex


title: brain, frontal cortex: pADX AM DR b_e1_le1

description: Doral Raphe


title: brain, frontal cortex: Sham PM LC b_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: ADX PM LC b_e1_le1

description: Locus Coeruleus


title: brain, hippocampus: ADX AM Hip b_e1_le1

description: Hippocampus


title: brain, hippocampus: ADX PM Hip b_e1_le1

description: Hippocampus


title: brain, amygdala: ADX PM A b_e1_le1

description: Amygdala

source_name: brain, amygdala


title: brain, frontal cortex: Sham AM LC b_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: pADX PM LC b_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: Sham PM DR b_e1_le1

description: Dorsal Raphe


title: brain, frontal cortex: ADX PM DR b_e1_le1

description: Dorsal Raphe


title: brain, frontal cortex: ADX AM LC b_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: pADX AM LC b_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: Sham AM DR b_e1_le1

description: Dorsal Raphe


title: brain, hippocampus: pADX PM Hip b_e1_le1

description: Hippocampus


title: brain, frontal cortex: ADX AM DR b_e1_le1

description: Dorsal Raphe


title: brain, amygdala: ADX AM A b_e1_le1

description: Amygdala


title: brain, hippocampi, left: ADX PM Hypo b_e1_le1

description: Hypothalamus

source_name: brain, hippocampi, left


title: brain, hippocampi, left: ADX AM Hypo b_e1_le1

description: Hypothalamus


title: brain, frontal cortex: pADX PM S b_e1_le1

description: Septum


title: brain, frontal cortex: pADX PM FC b_e1_le1

description: Frontal Cortex


title: brain, frontal cortex: ADX AM S b_e1_le1

description: Septum


title: brain, amygdala: pADX PM A b_e1_le1

description: Amygdala


title: brain, hippocampi, left: Sham AM Hypo b_e1_le1

description: Hypothalamus


title: brain, amygdala: pADX AM A b_e1_le1

description: Amygdada


title: brain, hippocampus: Sham PM Hip b_e1_le1

description: Hippocampus


title: brain, frontal cortex: Sham AM S b_e1_le1

description: Septum


title: brain, hippocampi, left: pADX PM Hypo b_e1_le1

description: Hypothalamus


title: brain, frontal cortex: Sham PM S b_e1_le1

description: Septum


title: brain, frontal cortex: ADX PM S b_e1_le1

description: Septum


title: brain, frontal cortex: ADX PM FC b_e1_le1

description: Frontal Cortex


title: brain, hippocampi, left: pADX AM Hypo b_e1_le1

description: Hypothalamus


title: brain, hippocampus: Sham AM Hip b_e1_le1

description: Hippocampus


title: brain, frontal cortex: Sham PM FC b_e1_le1

description: Frontal Cortex


title: brain, hippocampi, left: Sham PM Hypo b_e1_le1

description: Hypothalamus


title: brain, amygdala: Sham PM A b_e1_le1

description: Amygdala


title: brain, frontal cortex: Sham AM FC b_e1_le1

description: Frontal Cortex


title: brain, frontal cortex: pADX AM S b_e1_le1

description: Septum


title: brain, frontal cortex: pADX AM FC b_e1_le1

description: Frontal Cortex


title: brain, amygdala: Sham AM A b_e1_le1

description: Amygdala


title: brain, frontal cortex: pADX AM LC_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: pADX PM DR_e1_le1

description: Dorsal Raphe


title: brain, frontal cortex: ADX AM FC b_e1_le1

description: Frontal Cortex


title: brain, frontal cortex: ADX PM LC_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: Sham PM LC_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: pADX AM DR_e1_le1

description: Doral Raphe


title: brain, frontal cortex: pADX PM LC_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: ADX AM LC_e1_le1

description: Locus Coeruleus


title: brain, frontal cortex: ADX PM DR_e1_le1

description: Dorsal Raphe


title: brain, amygdala: Sham PM A_e1_le1

description: Amygdala


title: brain, amygdala: ADX AM A_e1_le1

description: Amygdala


title: brain, frontal cortex: ADX AM DR_e1_le1

description: Dorsal Raphe


title: brain, amygdala: Sham AM A_e1_le1

description: Amygdala


title: brain, hippocampus: ADX PM Hip_e1_le1

description: Hippocampus


title: brain, hippocampus: ADX AM Hip_e1_le1

description: Hippocampus


title: brain, amygdala: ADX PM A_e1_le1

description: Amygdala


title: brain, frontal cortex: Sham AM LC_e1_le1

description: Locus Coeruleus


title: brain, hippocampi, left: ADX AM Hypo_e1_le1

description: Hypothalamus


title: brain, frontal cortex: Sham PM DR_e1_le1

description: Dorsal Raphe


title: brain, hippocampus: pADX PM Hip_e1_le1

description: Hippocampus


title: brain, amygdala: pADX PM A_e1_le1

description: Amygdala


title: brain, unknown: C1A_e1_le1

description:
control 1 week A
Treatment, type=time_course, measurement=1.0 weeks

source_name: brain, unknown


title: brain, hippocampi, left: ADX PM Hypo_e1_le1

description: Hypothalamus


title: brain, hippocampi, left: pADX PM Hypo_e1_le1

description: Hypothalamus


title: brain, amygdala: pADX AM A_e1_le1

description: Amygdada


title: brain, frontal cortex: Sham AM DR_e1_le1

description: Dorsal Raphe


title: brain, hippocampi, left: Sham AM Hypo_e1_le1

description: Hypothalamus


title: brain, frontal cortex: ADX PM S_e1_le1

description: Septum


title: brain, hippocampus: Sham AM Hip_e1_le1

description: Hippocampus


title: brain, frontal cortex: ADX AM S_e1_le1

description: Septum


title: brain, hippocampi, left: pADX AM Hypo_e1_le1

description: Hypothalamus


title: brain, hippocampus: Sham PM Hip_e1_le1

description: Hippocampus


title: brain, frontal cortex: pADX PM S_e1_le1

description: Septum


title: brain, frontal cortex: Sham AM S_e1_le1

description: Septum


title: brain, frontal cortex: Sham PM S_e1_le1

description: Septum


title: brain, frontal cortex: pADX AM S_e1_le1

description: Septum


title: brain, hippocampi, left: Sham PM Hypo_e1_le1

description: Hypothalamus


title: brain, frontal cortex: ADX PM FC_e1_le1

description: Frontal Cortex


title: brain, frontal cortex: LabeledExtract3

description: Frontal Cortex


title: brain, unknown: 00FA_e1_le1

description:
Meningioma Primary Grade 1 U133A
Treatment, type=harvest, description=There was no treatment.  Tissue/cells must be flash frozen in liquid nitrogen within 1 minute of removal.


title: brain, unknown: 00LC_e1_le1

description:
Meningioma Recurrent Grade 2 U133A
Treatment, type=harvest, description=There was no treatment.  Tissue/cells must be flash frozen in liquid nitrogen within 1 minute of removal.


title: brain, unknown: 03AJ_e1_le1


title: brain, frontal cortex: pADX PM FC_e1_le1

description: Frontal Cortex


title: brain, frontal cortex: Sham PM FC_e1_le1

description: Frontal Cortex


title: brain, frontal cortex: pADX AM FC_e1_le1

description: Frontal Cortex


title: brain, frontal cortex: LabeledExtract2

description: Frontal Cortex


title: brain, unknown: 00HK_e1_le1

description:
Meningioma Primary Grade 2 U133A
Treatment, type=harvest, description=There was no treatment.  Tissue/cells must be flash frozen in liquid nitrogen within 1 minute of removal.


title: brain, unknown: 00PX_e1_le1

description:
Meningioma Reccurrent Grade 1 U133A
Treatment, type=harvest, description=There was no treatment.  Tissue/cells must be flash frozen in liquid nitrogen within 1 minute of removal.


title: X184LO (HG-U133A)

status: Public on May 31 2006

city: Stockholm

first: Alexander

last: Ploner

department: Medical Epidemiology and Biostatistics

country: Sweden

institute: Karolinska Institutet

description: Series of 159 tumors

hyb_protocol: Standard Affymetrix procedure

scan_protocol: Standard Affymetrix procedure

data_processing: Affymetrix Microarray Suite Version 5.0

source_name: Breast tumor

label_protocol: Approximately 10ug of total RNA was processed to produce biotynylated cRNA targets

extract_protocol: Qiagen RNeasy Mini Kit

tag: Breast tumor tissue

tag: RELAPSE

tag: DEATH

tag: SUBTYPE

value: Luminal A

tag: ELSTON

tag: See Series GSE1456 record for additional information


title: X283AN (HG-U133A)

description: Series of 159 tumors

value: No Subtype


title: X196SA (HG-U133A)

description: Series of 159 tumors

value: Normal Like


title: X059HO (HG-U133A)

description: Series of 159 tumors


title: X288BE (HG-U133A)

description: Series of 159 tumors


title: X014ER (HG-U133A)

description: Series of 159 tumors

value: Basal


title: X036AR (HG-U133A)

description: Series of 159 tumors

value: Luminal B


title: X327EN (HG-U133A)

description: Series of 159 tumors


title: X351OL (HG-U133A)

description: Series of 159 tumors


title: X138BR (HG-U133A)

description: Series of 159 tumors


title: X365MA (HG-U133A)

description: Series of 159 tumors


title: X048SA (HG-U133A)

description: Series of 159 tumors


title: X069EK (HG-U133A)

description: Series of 159 tumors


title: X282WI (HG-U133A)

description: Series of 159 tumors


title: X202NI (HG-U133A)

description: Series of 159 tumors


title: X015HE (HG-U133A)

description: Series of 159 tumors


title: X085RY (HG-U133A)

description: Series of 159 tumors


title: X379BA (HG-U133A)

description: Series of 159 tumors


title: X341UL (HG-U133A)

description: Series of 159 tumors


title: X304VE (HG-U133A)

description: Series of 159 tumors


title: X072TE (HG-U133A)

description: Series of 159 tumors


title: X146HO (HG-U133A)

description: Series of 159 tumors


title: X325OS (HG-U133A)

description: Series of 159 tumors


title: X095NI (HG-U133A)

description: Series of 159 tumors


title: X221LU (HG-U133A)

description: Series of 159 tumors


title: X154AN (HG-U133A)

description: Series of 159 tumors


title: X249LU (HG-U133A)

description: Series of 159 tumors


title: X258VE (HG-U133A)

description: Series of 159 tumors


title: X132VI (HG-U133A)

description: Series of 159 tumors


title: X128SA (HG-U133A)

description: Series of 159 tumors


title: X171SO (HG-U133A)

description: Series of 159 tumors


title: X275WE (HG-U133A)

description: Series of 159 tumors


title: X331HA (HG-U133A)

description: Series of 159 tumors


title: X336MO (HG-U133A)

description: Series of 159 tumors


title: X345VI (HG-U133A)

description: Series of 159 tumors


title: X123ER (HG-U133A)

description: Series of 159 tumors


title: X029AN (HG-U133A)

description: Series of 159 tumors


title: X244SO (HG-U133A)

description: Series of 159 tumors


title: X075DA (HG-U133A)

description: Series of 159 tumors


title: X019ER (HG-U133A)

description: Series of 159 tumors


title: X285FL (HG-U133A)

description: Series of 159 tumors


title: X150JO (HG-U133A)

description: Series of 159 tumors


title: X349LE (HG-U133A)

description: Series of 159 tumors


title: X049SA (HG-U133A)

description: Series of 159 tumors


title: X260LI (HG-U133A)

description: Series of 159 tumors


title: X052ZA (HG-U133A)

description: Series of 159 tumors


title: X170FA (HG-U133A)

description: Series of 159 tumors


title: X176TH (HG-U133A)

description: Series of 159 tumors


title: X056EN (HG-U133A)

description: Series of 159 tumors


title: X136ER (HG-U133A)

description: Series of 159 tumors


title: X284JE (HG-U133A)

description: Series of 159 tumors


title: X087BU (HG-U133A)

description: Series of 159 tumors


title: X081UL (HG-U133A)

description: Series of 159 tumors


title: X330IG (HG-U133A)

description: Series of 159 tumors


title: X092NO (HG-U133A)

description: Series of 159 tumors


title: X352AN (HG-U133A)

description: Series of 159 tumors


title: X199PO (HG-U133A)

description: Series of 159 tumors


title: X165AN (HG-U133A)

description: Series of 159 tumors


title: X157HA (HG-U133A)

description: Series of 159 tumors


title: X342BL (HG-U133A)

description: Series of 159 tumors


title: X183AN (HG-U133A)

description: Series of 159 tumors


title: X374BR (HG-U133A)

description: Series of 159 tumors


title: X307EG (HG-U133A)

description: Series of 159 tumors


title: X117KO (HG-U133A)

description: Series of 159 tumors


title: X142SW (HG-U133A)

description: Series of 159 tumors


title: X174HE (HG-U133A)

description: Series of 159 tumors


title: X371AS (HG-U133A)

description: Series of 159 tumors


title: X206RI (HG-U133A)

description: Series of 159 tumors


title: X240SM (HG-U133A)

description: Series of 159 tumors


title: X231CA (HG-U133A)

description: Series of 159 tumors


title: X218BE (HG-U133A)

description: Series of 159 tumors


title: X211WA (HG-U133A)

description: Series of 159 tumors


title: X360RI (HG-U133A)

description: Series of 159 tumors


title: X063PE (HG-U133A)

description: Series of 159 tumors


title: X112FR (HG-U133A)

description: Series of 159 tumors


title: X281BR (HG-U133A)

description: Series of 159 tumors


title: X213BI (HG-U133A)

description: Series of 159 tumors


title: X242KR (HG-U133A)

description: Series of 159 tumors


title: X225KA (HG-U133A)

description: Series of 159 tumors


title: X158KU (HG-U133A)

description: Series of 159 tumors


title: X243BE (HG-U133A)

description: Series of 159 tumors


title: X261EN (HG-U133A)

description: Series of 159 tumors


title: X161JO (HG-U133A)

description: Series of 159 tumors


title: X011DA (HG-U133A)

description: Series of 159 tumors


title: X372LU (HG-U133A)

description: Series of 159 tumors


title: X018GU (HG-U133A)

description: Series of 159 tumors


title: X210NI (HG-U133A)

description: Series of 159 tumors


title: X276EK (HG-U133A)

description: Series of 159 tumors


title: X137TH (HG-U133A)

description: Series of 159 tumors


title: X010BJ (HG-U133A)

description: Series of 159 tumors


title: X259AB (HG-U133A)

description: Series of 159 tumors


title: X040TH (HG-U133A)

description: Series of 159 tumors


title: X172SA (HG-U133A)

description: Series of 159 tumors


title: X125WA (HG-U133A)

description: Series of 159 tumors


title: X246TA (HG-U133A)

description: Series of 159 tumors


title: X076ER (HG-U133A)

description: Series of 159 tumors


title: X115LU (HG-U133A)

description: Series of 159 tumors


title: X178WA (HG-U133A)

description: Series of 159 tumors


title: X373LI (HG-U133A)

description: Series of 159 tumors


title: X333SI (HG-U133A)

description: Series of 159 tumors


title: X268AR (HG-U133A)

description: Series of 159 tumors


title: X219WO (HG-U133A)

description: Series of 159 tumors


title: X024BJ (HG-U133A)

description: Series of 159 tumors


title: X086LI (HG-U133A)

description: Series of 159 tumors


title: X084GE (HG-U133A)

description: Series of 159 tumors


title: X026NA (HG-U133A)

description: Series of 159 tumors


title: X074KA (HG-U133A)

description: Series of 159 tumors


title: X188AH (HG-U133A)

description: Series of 159 tumors


title: X297PE (HG-U133A)

description: Series of 159 tumors


title: X382GU (HG-U133A)

description: Series of 159 tumors


title: X003WI (HG-U133A)

description: Series of 159 tumors


title: X071AV (HG-U133A)

description: Series of 159 tumors


title: X319AN (HG-U133A)

description: Series of 159 tumors


title: X035SI (HG-U133A)

description: Series of 159 tumors


title: X214WI (HG-U133A)

description: Series of 159 tumors


title: X318KI (HG-U133A)

description: Series of 159 tumors


title: X166JO (HG-U133A)

description: Series of 159 tumors


title: X377DE (HG-U133A)

description: Series of 159 tumors


title: X310WI (HG-U133A)

description: Series of 159 tumors


title: X057FR (HG-U133A)

description: Series of 159 tumors


title: X376FR (HG-U133A)

description: Series of 159 tumors


title: X160LU (HG-U133A)

description: Series of 159 tumors


title: X296NY (HG-U133A)

description: Series of 159 tumors


title: X113SO (HG-U133A)

description: Series of 159 tumors


title: X185NY (HG-U133A)

description: Series of 159 tumors


title: X187OL (HG-U133A)

description: Series of 159 tumors


title: X164MY (HG-U133A)

description: Series of 159 tumors


title: X121LE (HG-U133A)

description: Series of 159 tumors


title: X361NO (HG-U133A)

description: Series of 159 tumors


title: X298LA (HG-U133A)

description: Series of 159 tumors


title: X031ER (HG-U133A)

description: Series of 159 tumors


title: X309EV (HG-U133A)

description: Series of 159 tumors


title: X054BO (HG-U133A)

description: Series of 159 tumors


title: X101GL (HG-U133A)

description: Series of 159 tumors


title: X264LA (HG-U133A)

description: Series of 159 tumors


title: X223LI (HG-U133A)

description: Series of 159 tumors


title: X055SV (HG-U133A)

description: Series of 159 tumors


title: X356AL (HG-U133A)

description: Series of 159 tumors


title: X380MO (HG-U133A)

description: Series of 159 tumors


title: X089HO (HG-U133A)

description: Series of 159 tumors


title: X204FA (HG-U133A)

description: Series of 159 tumors


title: brain, frontal cortex: sample DME01-1991 extraction_le1

status: Public on May 02 2006

description:
Sample DME01-1991 correspond to a black male,  57yo with a pre-mortem history of AIDS with no HIVE nor dementia.  Brain  unremarkable. No HIV was detected by  viral load quantification method (gag-primers)
Treatment, type=dissect


title: X045OL (HG-U133A)

description: Series of 159 tumors


title: brain, frontal cortex: sample D03-0046 extraction_le1

description:
Sample D03-0046   correspond to a black female, 45yo  correspond to a black female, 25yo history of AIDS with HIVE and dementia. HIVE situation was confirmed by microscopic observation. HIV RNA was positively determined by viral load quantification method (gag-primers)
Treatment, type=dissect


title: X215HE (HG-U133A)

description: Series of 159 tumors


title: X027JO (HG-U133A)

description: Series of 159 tumors


title: X126AS (HG-U133A)

description: Series of 159 tumors


title: X111MA (HG-U133A)

description: Series of 159 tumors


title: X005JO (HG-U133A)

description: Series of 159 tumors


title: brain, frontal cortex: sample A01-044 extraction_le1

description:
Sample A00-44 correspond to a black female, 25yo with premortem history of AIDS with HIVE and dementia. HIVE situation was confirmed by microscopic observation.  HIV RNA  was positively determined by viral load quantification method (gag-primers)
Treatment, type=dissect


title: X229LA (HG-U133A)

description: Series of 159 tumors


title: brain, cerebral cortex: Sham20_e1_le1

description:
Sham 20
Treatment, type=incubate, description=Sham (normoxic) preconditioning

source_name: brain, cerebral cortex


title: brain, cerebral cortex: Sham17_e1_le1

description:
Sham 17
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC20_e1_le1

description:
PC 20
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: PC17_e1_le1

description:
PC 17
Treatment, type=incubate, description=Hypoxic preconditioning


title: X347JA (HG-U133A)

description: Series of 159 tumors


title: brain, cerebral cortex: PC19_e1_le1

description:
PC 19
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: PC16_e1_le1

description:
PC 16
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, frontal cortex: sample DME02-0053 extraction_le1

description:
Sample DME02-0053 correspond to a white male,  47yo with a pre-mortem history of AIDS with no HIVE nor dementia.  Brain  Normal. No HIV was detected by  viral load quantification method (gag-primers)
Treatment, type=dissect


title: brain, cerebral cortex: Sham14_e1_le1

description:
Sham 14
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: X350JO (HG-U133A)

description: Series of 159 tumors


title: brain, cerebral cortex: Sham19_e1_le1

description:
Sham 19
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: X041LA (HG-U133A)

description: Series of 159 tumors


title: brain, cerebral cortex: Sham11_e1_le1

description:
Sham 11
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: Sham13_e1_le1

description:
Sham 13
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC15_e1_le1

description:
PC 15
Treatment, type=incubate, description=Hypoxic preconditioning


title: X122FO (HG-U133A)

description: Series of 159 tumors


title: brain, cerebral cortex: Sham18_e1_le1

description:
Sham 18
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC12_e1_le1

description:
PC 12
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham9_e1_le1

description:
Sham 9
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC13_e1_le1

description:
PC 13
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: PC14_e1_le1

description:
PC 14
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham16_e1_le1

description:
Sham 16
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC9_e1_le1

description:
PC9
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham6_e1_le1

description:
Sham 6
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC8_e1_le1

description:
PC8
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham7_e1_le1

description:
Sham 7
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC11_e1_le1

description:
PC 11
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: PC6_e1_le1

description:
PC6
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham1_e1_le1

description:
Sham 1
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: Sham8_e1_le1

description:
Sham 8
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC3_e1_le1

description:
PC3
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham12_e1_le1

description:
Sham 12
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: Sham2_e1_le1

description:
Sham 2
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC10_e1_le1

description:
PC10
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham5_e1_le1

description:
Sham 5
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC18_e1_le1

description:
PC 18
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham3_e1_le1

description:
Sham 3
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: Sham15_e1_le1

description:
Sham 15
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC7_e1_le1

description:
PC7
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: PC4_e1_le1

description:
PC4
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham4_e1_le1

description:
Sham 4
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, cerebral cortex: PC5_e1_le1

description:
PC5
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: PC2_e1_le1

description:
PC2
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: QIAGEN RNeasy Protect Maxi Kit_le1

description:
PC1
Treatment, type=incubate, description=Hypoxic preconditioning


title: brain, cerebral cortex: Sham10_e1_le1

description:
Sham 10
Treatment, type=incubate, description=Sham (normoxic) preconditioning


title: brain, Right Frontal Lobe: Extract57_le2

status: Public on Mar 08 2006

description:
GBM
Treatment, type=remove

hyb_protocol: Standard Affymetrix protocols were used.

source_name: brain, Right Frontal Lobe

label_protocol: Probes were prepared using standard Affymetrix protocols and hybridized to Affymetrix HG-U133A and HG-U133B arrays (Affymetrix, Santa Clara, CA).

extract_protocol: RNA extraction was performed as described previously (Mischel PS, Shai R, Shi T, et al Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene, 2003;22:2361-73) and analyzed on both a spectrophotometer and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).

tag: tissue

value: brain, Right Frontal Lobe

tag: histology

value: MIXED

tag: tumor number (as appears in figure 3)

tag: gender

value: FEMALE

tag: grade

tag: living

value: DECEASED

tag: survival time

tag: survival cluster

tag: array


title: brain, Right Cerebellum: Extract53_le2

description:
GBM
Treatment, type=remove

scan_protocol: Standard Affymetrix protocols were used.

source_name: brain, Right Cerebellum

value: brain, Right Cerebellum

value: ASTRO

value: ALIVE


title: brain, Left Temporal Lobe: Extract44_le2

description:
GBM
Treatment, type=remove

source_name: brain, Left Temporal Lobe

value: brain, Left Temporal Lobe

value: MALE


title: brain, Right Frontal Lobe: Extract56_le1

description:
GBM
Treatment, type=remove

value: OLIGO


title: brain, Right Frontal Lobe: Extract55_le2

description:
GBM
Treatment, type=remove


title: brain, Left Temporal Lobe: Extract44_le1

description:
GBM
Treatment, type=remove


title: brain, Right Frontal Lobe: Extract55_le1

description:
GBM
Treatment, type=remove


title: brain, Right Cerebellum: Extract53_le1

description:
GBM
Treatment, type=remove


title: brain, Left Parietal Lobe: Extract41_le2

description:
GBM
Treatment, type=remove

source_name: brain, Left Parietal Lobe

value: brain, Left Parietal Lobe


title: brain, Left Parietal Lobe: Extract41_le1

description:
GBM
Treatment, type=remove


title: brain, Left Parietal Lobe: Extract39_le1

description:
GBM
Treatment, type=remove


title: brain, Left Parietal Lobe: Extract39_le2

description:
GBM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract15_le2

description:
AO
Treatment, type=remove

source_name: brain, Left frontal Lobe

value: brain, Left frontal Lobe


title: brain, Left frontal Lobe: Extract16_le1

description:
AO
Treatment, type=remove


title: brain, Right Frontal Lobe: Extract54_le1

description:
GBM
Treatment, type=remove


title: brain, Right Frontal Lobe: Extract56_le2

description:
GBM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract17_le2

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: Extract17_le1

description:
AO
Treatment, type=remove


title: brain, Left Parietal Lobe: Extract40_le1

description:
GBM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract15_le1

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: Extract14_le1

description:
AO
Treatment, type=remove


title: brain, Right Frontal Lobe: Extract54_le2

description:
GBM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract13_le2

description:
AO
Treatment, type=remove


title: brain, Left Parietal Lobe: Extract40_le2

description:
GBM
Treatment, type=remove


title: brain, Right Frontal Lobe: Extract57_le1

description:
GBM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract16_le2

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: Extract14_le2

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: Extract13_le1

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: Extract11_le2

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: Extract12_le2

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: Extract10_le2

description:
AM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract7_le1

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract11_le1

description:
AO
Treatment, type=remove


title: brain, Right Temporal Lobe: Extract76_le2

description:
GBM
Treatment, type=remove

source_name: brain, Right Temporal Lobe

value: brain, Right Temporal Lobe


title: brain, Left frontal Lobe: Extract8_le2

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract9_le1

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract9_le2

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract6_le2

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract8_le1

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: ASTRO III 587_e1_le2

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract6_le1

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract12_le1

description:
AO
Treatment, type=remove


title: brain, Left frontal Lobe: ASTRO III 587_e1_le1

description:
AA
Treatment, type=remove


title: brain, Left frontal Lobe: Extract5_le1

description:
AM
Treatment, type=remove


title: brain, Right Parietal Lobe: Extract72_le2

description:
GBM
Treatment, type=remove

source_name: brain, Right Parietal Lobe

value: brain, Right Parietal Lobe


title: brain, Left frontal Lobe: Extract5_le2

description:
AM
Treatment, type=remove


title: brain, Right Temporal Lobe: Extract76_le1

description:
GBM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract10_le1

description:
AM
Treatment, type=remove


title: brain, Right Parietal Lobe: Extract72_le1

description:
GBM
Treatment, type=remove


title: brain, Left frontal Lobe: Extract7_le2

description:
AA
Treatment, type=remove


title: OXFU_1286

status: Public on Feb 16 2006

description: Tumor samples from untreated primary breast cancer patients.

source_name: breast

extract_protocol: Isolation of RNA was performed using the Trizol method (Invitrogen) according to the manufacturer's instructions and was purified using RNeasy mini-columns (Qiagen, Valencia, CA). The quality of the RNA obtained from each tumour sample was assessed based on the RNA profile generated by the bioanalyzer (Agilent Inc)olation of RNA was performed using the Trizol method (Invitrogen) according to the manufacturer's instructions and was purified using RNeasy mini-columns (Qiagen, Valencia, CA). The quality of the RNA obtained from each tumour sample was assessed based on the RNA profile generated by the bioanalyzer (Agilent Inc)

tag: sample name

tag: node

tag: size

tag: ggi

tag: er

tag: time rfs

tag: distant rfs


title: OXFU_1415

tag: age


title: OXFU_1065


title: brain, Right Parietal Lobe: Extract71_le1

description:
GBM
Treatment, type=remove

tag: tissue


title: OXFU_1328


title: OXFU_1373


title: OXFU_1605


title: OXFU_559


title: OXFU_1183


title: OXFU_549


title: OXFU_1248


title: OXFU_535


title: OXFU_869


title: brain, Right Parietal Lobe: Extract71_le2

description:
GBM
Treatment, type=remove

tag: histology


title: OXFU_547


title: OXFU_662


title: OXFU_513


title: OXFU_449


title: OXFU_531


title: OXFU_557


title: OXFU_544


title: OXFU_608


title: OXFU_419


title: OXFU_530


title: OXFU_382


title: OXFU_476


title: OXFU_533


title: OXFU_522


title: OXFU_360


title: OXFU_366


title: OXFU_484


title: OXFU_316


title: OXFU_247


title: OXFU_397


title: OXFU_573


title: OXFU_348


title: OXFU_1210


title: OXFU_245


title: OXFU_491


title: OXFU_598


title: OXFU_543


title: OXFU_254


title: OXFU_281


title: OXFU_373


title: OXFU_145


title: KIU_88A67


title: OXFU_88


title: OXFU_93


title: OXFU_181


title: OXFU_320


title: OXFU_217


title: KIU_89A64


title: OXFU_90


title: OXFU_157


title: OXFU_16


title: OXFU_12


title: OXFU_127


title: OXFU_104


title: OXFU_223


title: OXFU_220


title: OXFU_57


title: OXFU_138


title: KIU_87A79


title: KIU_36C17


title: OXFU_126


title: KIU_65A68


title: KIU_74A63


title: OXFU_37


title: KIU_86A40


title: OXFU_53


title: KIU_292C66


title: KIU_28C76


title: KIU_316C64


title: KIU_42C67


title: KIU_278C80


title: KIU_308C93


title: KIU_279C61


title: KIU_43C47


title: KIU_303C36


title: KIU_282C51


title: KIU_284C63


title: KIU_309C49


title: KIU_52A90


title: KIU_272C88


title: KIU_259C74


title: KIU_24C30


title: KIU_304C89


title: KIU_280C43


title: KIU_314B55


title: KIU_247C76


title: KIU_260C91


title: KIU_5B97


title: KIU_286C91


title: KIU_268C87


title: KIU_220C70


title: KIU_266C51


title: KIU_243C70


title: KIU_229C44


title: KIU_197B95


title: KIU_242C21


title: KIU_199B55


title: KIU_231C80


title: KIU_205B99


title: KIU_136B04


title: KIU_172B19


title: KIU_233C91


title: KIU_124B25


title: KIU_188B13


title: KIU_151B84


title: KIU_155B52


title: KIU_248C91


title: KIU_134B33


title: KIU_196B81


title: KIU_113B11


title: KIU_101B88


title: KIU_164B81


title: KIU_140B91


title: KIU_227C50


title: KIU_177B67


title: KIU_111B51


title: KIU_120B73


title: KIU_144B49


title: KIU_163B27


title: KIU_127B00


title: KIU_105B13


title: KIU_106B55


title: KIU_184B38


title: brain, cerebral cortex: NMDA 60 3_le1

status: Public on Feb 14 2006

description:
NMDA60 (Experiment shortNMDA: Run 19222)
Treatment, type=time_course, description=primary cortical neurons were treated with 1 mM NMDA for increasing periods of time (10 to 360 min)., measurement=60.0 m


title: brain, cerebral cortex: NMDA 60 2_le1


title: brain, cerebral cortex: NMDA 1mM 1HOUR_le1

description:
NMDA 1h (Experiment NMDA2-Run 9600)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=60.0 m


title: brain, cerebral cortex: 9156_e3_le1

description:
NMDA 1h 7/8 RC (Experiment NMDA1-Run 13384))
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=60.0 m


title: brain, cerebral cortex: NMDA30 7/8RC_le1

description:
NMDA 30 7/8RC (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA 1mM 30'_le1

description:
NMDA 30 (Experiment NMDA2-Run 9600)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA 1_le1

description:
nmda1  (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 30 min with NMDA 1mM, the agonist was then washed out  and the cells were harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: 9150_e3_le1

description:
NMDA 30 7/8 (Experiment NMDA1-Run 13384)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA 2_le1

description:
nmda2  (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 30 m with NMDA 1mM,  agonists was then washed out  and the cells were harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA 3_le1

description:
nmda3 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 30 min with NMDA 1mM, the agonist was then washed out  and the cells were harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: 4R-4(2/5CG)_le1

description:
4R-5 2/5CG (Experiment 4Rlong: Run 19283)
Treatment, type=timepoint, description=Primary cortical neurons were treated for 18h with a new non competitive antagonist for nicotinic receptors (4R 2uM), the antagonist was then washed out and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: NMDA30 6/24_le1

description:
NMDA 30 6/24(Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA30 7/8_le1

description:
NMDA 30 7/8 (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA 5_le1

description:
nmda5  (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 30 min with NMDA 1mM, the agonist  was then washed out  and the cells were harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA 4_le1

description:
nmda4  (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 30 m wiht NMDA 1mM. The agonist was then washed out  and the cells were harvested 24h later, measurement=30.0 m


title: brain, cerebral cortex: NMDA 30 2_le1

description:
NMDA30 (Experiment shortNMDA: Run 19222)
Treatment, type=time_course, description=primary cortical neurons were treated with 1 mM NMDA for increasing periods of time (10 to 360 min)., measurement=30.0 m


title: brain, cerebral cortex: NMDA 30 3_le1


title: brain, cerebral cortex: NMDA1H 6/24_le1

description:
NMDA 1H 6/24 (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=60.0 m


title: brain, cerebral cortex: NMDA1H 7/8_le1

description:
NMDA 1H 7/8 (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=60.0 m


title: brain, cerebral cortex: NMDA 30 4_le1


title: brain, cerebral cortex: NMDA1H 7/8RC_le1

description:
NMDA 1h 7/8 RC (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=60.0 m


title: brain, cerebral cortex: NMDA1H 5/7_le1

description:
NMDA 1H (5/7) (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=60.0 m


title: brain, cerebral cortex: NMDA 360 2_le1

description:
NMDA360 (Experiment shortNMDA: Run 19222)
Treatment, type=time_course, description=primary cortical neurons were treated with 1 mM NMDA for increasing periods of time (10 to 360 min)., measurement=360.0 m


title: brain, cerebral cortex: NMDA 60 4_le1

description:
NMDA60 (Experiment shortNMDA: Run 19222)
Treatment, type=time_course, description=primary cortical neurons were treated with 1 mM NMDA for increasing periods of time (10 to 360 min)., measurement=60.0 m


title: brain, cerebral cortex: NMDA30 5/7_le1

description:
NMDA 30 5/7(Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=60.0 m


title: brain, cerebral cortex: NMDA 180 2_le1

description:
NMDA180 (Experiment shortNMDA: Run 19222)
Treatment, type=time_course, description=primary cortical neurons were treated with 1 mM NMDA for increasing periods of time (10 to 360 min)., measurement=180.0 m


title: brain, cerebral cortex: NMDA 180 3_le1


title: brain, cerebral cortex: NMDA 180 4_le1


title: brain, cerebral cortex: NMDA 369 4_le1


title: brain, cerebral cortex: NMDA 360 3_le1


title: brain, cerebral cortex: NIC + NMDA 5_le1

description:
nic + nmda5 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM ,NMDA 1mM was added for 30 min, both agonists were then washed out  and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: NIC + NMDA 4_le1

description:
nic + nmda4 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM ,NMDA 1mM was added for 30 min, both agonists were then washed out  and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: NIC + NMDA 3_le1

description:
nic + nmda3 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM ,NMDA 1mM was added for 30 min, both agonists were then washed out  and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: 4R-4(2/5)_le1

description:
4R-4 2/5 (Experiment 4Rlong: Run 19283)
Treatment, type=timepoint, description=Primary cortical neurons were treated for 18h with a new non competitive antagonist for nicotinic receptors (4R 2uM), the antagonist was then washed out and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: NIC + NMDA 2_le1

description:
nic + nmda2  (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM ,NMDA 1mM was added for 30 min, both agonists were then washed out  and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: 4R-3(1/29)_le1

description:
4R-3 1/29 (Experiment 4Rlong: Run 19283)
Treatment, type=timepoint, description=Primary cortical neurons were treated for 18h with a new non competitive antagonist for nicotinic receptors (4R 2uM), the antagonist was then washed out and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: Nic 5_le1

description:
nic 5 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM, agonist was then washed out  and the cells were harvested 24h later, measurement=18.0 h


title: brain, cerebral cortex: 4R 2 (4/22)_le1

description:
4R 2 (Experiment 4R18h: Run 19869)
Treatment, type=timepoint, description=Primary cortical neurons were treated for 18h with a new non competitive antagonist for nicotinic receptors (4R 2uM), and then the cells were harvested, measurement=18.0 h


title: brain, cerebral cortex: Nic5_le1

description:
Nic 3 (Experiment Nic 15 - Run 23145)
Treatment, type=timepoint, description=primary cortical neurons were treated with nicotine 10 microMolar for 15 minutes, medium was then changed to remove the agonist and cells were harvested 45 min later, measurement=15.0 m


title: brain, cerebral cortex: Nic 4_le1

description:
nic 4 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM, agonist was then washed out  and the cells were harvested 24h later, measurement=18.0 h


title: brain, cerebral cortex: Nic 3_le1

description:
nic 3 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM, agonist was then washed out  and the cells were harvested 24h later, measurement=18.0 h


title: brain, cerebral cortex: Nico 8/30_le1

description:
nico 18h 8/30/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM then were harvested, measurement=18.0 h


title: brain, cerebral cortex: Nic 1_le1

description:
nic 1 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM , agonist was then washed out  and the cells were harvested 24h later, measurement=18.0 h


title: brain, cerebral cortex: Nic 2_le1

description:
nic 2 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM , agonist was then washed out  and the cells were harvested 24h later, measurement=18.0 h


title: brain, cerebral cortex: Nico + NMDA 8/30_le1

description:
nico 18h + nmda 1h 8/30/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM then NMDA 1 mM was added and the cells were harvested 1h later, measurement=19.0 h


title: brain, cerebral cortex: NIC + NMDA 1_le1

description:
nic + nmda1  (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM ,NMDA 1mM was added for 30 min, both agonists were then washed out  and the cells were harvested 24h later, measurement=24.0 h


title: brain, cerebral cortex: Nic4_le1

description:
Nic 2 (Experiment Nic 15 - Run 23145)
Treatment, type=timepoint, description=primary cortical neurons were treated with nicotine 10 microMolar for 15 minutes, medium was then changed to remove the agonist and cells were harvested 45 min later, measurement=15.0 m


title: brain, cerebral cortex: Nico + NMDA 8/23_le1

description:
nico 18h + nmda 1h 8/23/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM then NMDA 1mM was added and the cells were harvested 1h later, measurement=19.0 h


title: brain, cerebral cortex: Nico + NMDA 9/06_le1

description:
nico 18h + nmda 1h 9/06/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM then NMDA 1 mM was added and the cells were harvested 1h later, measurement=19.0 h


title: brain, cerebral cortex: 4R 1 (4/14)_le1

description:
4R 1 (Experiment 4R18h: Run 19869)
Treatment, type=timepoint, description=Primary cortical neurons were treated for 18h with a new non competitive antagonist for nicotinic receptors (4R 2uM), and then the cells were harvested, measurement=18.0 h


title: brain, cerebral cortex: Nico 8/23_le1

description:
nico 18h 8/23/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=time_course, description=primary cortical neurons were treated for 18 h with nicotine 10uM then were harvested, measurement=18.0 h


title: brain, cerebral cortex: Nico 9/06_le1

description:
nico 18h 9/06/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 18 h with nicotine 10uM then were harvested, measurement=18.0 h


title: brain, cerebral cortex: 4R 3 (4/28)_le1

description:
4R 3 (Experiment 4R18h: Run 19869)
Treatment, type=timepoint, description=Primary cortical neurons were treated for 18h with a new non competitive antagonist for nicotinic receptors (4R 2uM), and then the cells were harvested, measurement=18.0 h


title: brain, cerebral cortex: NMDA 10 2_le1

description:
NMDA10 (Experiment shortNMDA: Run 19222)
Treatment, type=time_course, description=primary cortical neurons were treated with 1 mM NMDA for increasing periods of time (10 to 360 min)., measurement=10.0 m


title: brain, cerebral cortex: NMDA 1mM 10'_le1

description:
NMDA 10 (Experiment NMDA2-Run 9600)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=10.0 m


title: brain, cerebral cortex: 9154_e3_le1

description:
NMDA 10 (7/8 RC) (Experiment NMDA1-Run 13384)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=10.0 m


title: brain, cerebral cortex: NMDA 10 3_le1


title: brain, cerebral cortex: Nic1_le1

description:
Nic 1 (Experiment Nic 15 - Run 23145)
Treatment, type=timepoint, description=primary cortical neurons were treated with nicotine 10 microMolar for 15 minutes, medium was then changed to remove the agonist and cells were harvested 45 min later, measurement=15.0 m


title: brain, cerebral cortex: NMDA10 7/8RC_le1

description:
NMDA 10 (7/8 RC) (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=10.0 m


title: brain, cerebral cortex: NMDA 10 4_le1


title: brain, cerebral cortex: NMDA10 6/24_le1

description:
NMDA 10 (6/24) (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=10.0 m


title: brain, cerebral cortex: 15002_e2_le1

description:
nic + nmda1  (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 15004_e2_le1

description:
nic + nmda3 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 15005_e2_le1

description:
nic + nmda4 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 15003_e2_le1

description:
nic + nmda2  (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: Co1_le1

description:
Co 1 (Experiment Nic 15 - Run 23145)
Treatment, type=timepoint, measurement=0.0 m


title: brain, cerebral cortex: Co5_le1

description:
Co 3 (Experiment Nic 15 - Run 23145)
Treatment, type=timepoint, measurement=0.0 m


title: brain, cerebral cortex: Co4_le1

description:
Co 2 (Experiment Nic 15 - Run 23145)
Treatment, type=timepoint, measurement=0.0 m


title: brain, cerebral cortex: NMDA 8/23_le1

description:
nmda 1h 8/23/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 1 h with NMDA 1mM then were harvested, measurement=1.0 h


title: brain, cerebral cortex: 14993_e2_le1

description:
nic 2 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14994_e2_le1

description:
nic 3 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14995_e2_le1

description:
nic 4 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 9149_e2_le1

description:
NMDA 10 (7/8) (Experiment NMDA1-Run 13384)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=10.0 m


title: brain, cerebral cortex: 15006_e2_le1

description:
nic + nmda5 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: NMDA10 7/8_le1

description:
NMDA 10 (7/8) (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=10.0 m


title: brain, cerebral cortex: NMDA10 5/7_le1

description:
NMDA 10 (5/7) (Experiment NMDA1-Run 9136)
Treatment, type=time_course, description=samples are treated for 10, 30 or 60 min with NMDA 1mM, the agonist is then washed out and the cells are harvested 24h later, measurement=10.0 m


title: brain, cerebral cortex: NMDA 9/06_le1

description:
nmda 1h 9/06/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 1 h with NMDA 1mM then were harvested, measurement=1.0 h


title: brain, cerebral cortex: NMDA 8/30_le1

description:
nmda 1h 8/30/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, description=primary cortical neurons were treated for 1 h with NMDA 1mM then were harvested, measurement=1.0 h


title: brain, cerebral cortex: 15001_e2_le1

description:
nmda5  (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 15000_e2_le1

description:
nmda4  (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14992_e2_le1

description:
nic 1 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14988_e2_le1

description:
Control 2 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14989_e2_le1

description:
Control 3 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14987_e2_le1

description:
Control 1 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14991_e2_le1

description:
Control 5 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14990_e2_le1

description:
Control 4 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: Co4 (2/5CG)_le1

description:
CO (Experiment 4Rlong: Run 19283)
Treatment, type=timepoint, measurement=0.0 m


title: brain, cerebral cortex: Co4 (2/5)_le1


title: brain, cerebral cortex: Co 2 (4/22)_le1

description:
CO 2 (Experiment 4R18h: Run 19869)
Treatment, type=timepoint, measurement=0.0 d


title: brain, cerebral cortex: Co 1 (4/14)_le1

description:
CO 1 (Experiment 4R18h: Run 19869)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: 14996_e2_le1

description:
nic 5 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14999_e2_le1

description:
nmda3 (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14997_e2_le1

description:
nmda1  (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: 14998_e2_le1

description:
nmda2  (Experiment Neuroprotection4- Run 21823)
Treatment, type=timepoint, description=Same sample used for Experiment Neuroprotection4-Run 14985, samples were rerun due to oven failure, measurement=0.0 h


title: brain, cerebral cortex: Control 2_le1

description:
Control 2 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: Control 1_le1

description:
Control 1 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: Co 3 (4/28)_le1

description:
CO 3 (Experiment 4R18h: Run 19869)
Treatment, type=timepoint, measurement=0.0 m


title: brain, cerebral cortex: Control 4_le1

description:
Control 4 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: Control 5_le1

description:
Control 5 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: CO3_le1

description:
CO (Experiment shortNMDA: Run 19222)
Treatment, type=time_course, measurement=0.0 m


title: brain, cerebral cortex: CO4_le1


title: brain, cerebral cortex: Co3_le1


title: brain, cerebral cortex: CO2_le1


title: brain, cerebral cortex: Control 3_le1

description:
Control 3 (Experiment Neuroprotection4- Run 14985)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: Control 9/06_le1

description:
Control 9/06/02 (Experiment Neuroprotection3-Run 13276)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: Control_le1

description:
Control (Experiment NMDA2-Run 9600)
Treatment, type=time_course, measurement=0.0 m


title: brain, cerebral cortex: Control 8/23_le1

description:
Control 8/23/02 (Experiment Neuroprotection3- Run 13276)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: Co 6/24_le1

description:
Control (6/24) (Experiment NMDA1-Run 9136)
Treatment, type=time_course, measurement=0.0 m


title: brain, cerebral cortex: Control 8/30_le1

description:
Control 8/30/02 (Experiment Neuroprotection3-Run 13276)
Treatment, type=timepoint, measurement=0.0 h


title: brain, cerebral cortex: Co 7/8 RC_le1

description:
Control (7/8RC) (Experiment NMDA1 (Run 9136))
Treatment, type=time_course, measurement=0.0 m


title: brain, cerebral cortex: Co 7/8_le1

description:
Control 7/8 (Experiment NMDA1-Run 9136)
Treatment, type=time_course, measurement=0.0 m


title: brain, cerebral cortex: Co 5/7_le1

description:
Control (5/7) (Experiment NMDA1-Run 9136))
Treatment, type=time_course, measurement=0.0 m


title: Multiple Organs, adrenal medulla: Sample 4_le1

status: Public on Jan 13 2006

description:
Rats were immobilized for 2 hours.
Treatment, type=behavioral_stimulus


title: Multiple Organs, adrenal medulla: Sample 1_le1

description:
Unstressed animals
Treatment, type=behavioral_stimulus, description=Unstressed animals


title: spinal cord, spinal cord: G1C_le1

description:
14 NT C4
Treatment, type=add, description=10ng/mL Ciliary neurotrophiic factor, 4d

source_name: spinal cord, spinal cord


title: spinal cord, spinal cord: G5F_le1

description: 14 NT control


title: spinal cord, spinal cord: G6F_le1

description: 14 NT control


title: spinal cord, spinal cord: G4F_le1

description: 14 NT control


title: spinal cord, spinal cord: G3F_le1

description: 14 NT control


title: Multiple Organs, adrenal medulla: Sample 3_le1

description:
Rats were immobilized 2 hours
Treatment, type=behavioral_stimulus, description=Rats were immobilized for 2 hours


title: spinal cord, spinal cord: G6C_le1


title: Multiple Organs, adrenal medulla: Sample 2_le1

description:
Unstressed animals
Treatment, type=behavioral_stimulus, description=unstressed animals


title: spinal cord, spinal cord: G4B_le1

description:
14 NT B4
Treatment, type=add, description=10ng/mL Bonemorphogentic Protein, 4d


title: spinal cord, spinal cord: G6B_le1


title: spinal cord, spinal cord: G5C_le1


title: spinal cord, spinal cord: G2F_le1

description: 14 NT control


title: spinal cord, spinal cord: G5B_le1


title: spinal cord, spinal cord: G4C_le1


title: spinal cord, spinal cord: G3C_le1


title: spinal cord, spinal cord: G3B_le1


title: spinal cord, spinal cord: G2B_le1


title: brain, cerebral cortex: Rat_03-63_NroLep_Lipska_e1_le1

description: Rat frontal cortex RNA - Neuroleptic Experiment_haloperidol medium


title: spinal cord, spinal cord: G1B_le1


title: spinal cord, spinal cord: G2C_le1


title: spinal cord, spinal cord: G1F_le1

description: 14 NT control


title: brain, cerebral cortex: Rat_03-57_NroLep_Lipska_e1_le1

description: Rat frontal cortex RNA - Neuroleptic Experiment_clozapine low


title: brain, cerebral cortex: Rat_03-62_NroLep_Lipska_e1_le1

description: Rat frontal cortex RNA - Neuroleptic Experiment_haloperidol low


title: brain, cerebral cortex: Rat_03-59_NroLep_Lipska_e1_le1

description: Rat frontal cortex RNA - Neuroleptic Experiment_haloperidol high


title: brain, cerebral cortex: Rat_03-52_NroLep_Lipska_e1_le1

description: Rat frontal cortex RNA - Neuroleptic Experiment_vehicle


title: brain, cerebral cortex: Rat_03-64_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-54_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-61_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-60_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-58_NroLep_Lipska_e1_le1


title: brain, unknown: 03AM_e1_le1

description:
Meningioma Primary Grade 1 Cell Line
Treatment, type=grow, description=Cells were taken from the original tumor tissue and grown in culture.


title: brain, cerebral cortex: Rat_03-56_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-43_NroLep_Lipska_e1_le1

description: Rat frontal cortex RNA - Neuroleptic Experiment_clozapine medium


title: brain, unknown: 03BE_e1_le1


title: brain, cerebral cortex: Rat_03-44_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-55_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-51_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-49_NroLep_Lipska_e1_le1

description: Rat frontal cortex RNA - Neuroleptic Experiment_clozapine high


title: brain, cerebral cortex: Rat_03-53_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-46_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-48_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-50_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-47_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-45_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-40_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-41_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-23_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-42_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-34_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-36_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-25_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-33_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-30_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-22_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-35_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-27_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-39_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-31_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-21_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-38_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-16_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-26_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-24_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-32_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-28_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-29_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-13_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-20_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-18_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-19_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-37_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-15_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-17_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-14_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-09_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-02_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-10_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-06_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-11_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-04_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-08_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-03_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-12_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-07_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-131_TTX_Lipska_e1_le1

description: Rat frontal cortex RNA - VH TTX Experiment_TTX


title: brain, cerebral cortex: Rat_02-145_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-143_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-141_TTX_Lipska_e1_le1

description: Rat frontal cortex RNA - VH TTX Experiment_sham


title: brain, cerebral cortex: Rat_02-140_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-142_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-133_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-134_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-138_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_03-05_NroLep_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-135_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-129_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-136_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-128_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-144_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-139_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-137_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-132_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-130_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-40_VHL_Lipska_e1_le1

description: Rat frontal cortex RNA - VH Lesion Experiment_sham


title: brain, cerebral cortex: Rat_02-127_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-41_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-57_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-126_TTX_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-54_VHL_Lipska_e1_le1

description: Rat frontal cortex RNA - VH Lesion Experiment_lesion


title: brain, cerebral cortex: Rat_02-51_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-49_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-55_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-48_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-38_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-43_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-56_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-53_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-50_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-46_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-52_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-47_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-42_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-44_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-45_VHL_Lipska_e1_le1


title: brain, cerebral cortex: Rat_02-39_VHL_Lipska_e1_le1


title: B32-T

status: Public on Jul 28 2005

city: New York

first: Agnes

last: Viale

state: NY

address: 1275 York Avenue

department: Molecular Biology

institute: Memorial Sloan Kettering Cancer Center

description: RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors

hyb_protocol: Standard Affymetrix protocol

scan_protocol: Standard Affymetrix protocol

data_processing: MAS 5.0

source_name: Primary Breast Cancer

label_protocol: Standard Affymetrix protocol

extract_protocol: RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors

tag: name

tag: age at dx

tag: tumor size (cm)

tag: pos lymph nodes

tag: all lymph nodes

tag: path er status

value: N

tag: path pr status

tag: her2 status

tag: van't veer signature

tag: binary 5y met event

tag: met event

tag: mfs (yr)

tag: lm event

tag: lmfs (yr)

tag: bm event

tag: bmfs (yr)


title: brain, cerebral cortex: Rat_02-36_VHL_Lipska_e1_le1


title: B3-T

value: P

value: 1+ (only 1 core pos.)

value: Bad Prognosis


title: brain, cerebral cortex: Rat_02-37_VHL_Lipska_e1_le1


title: B26-T


title: B31-T


title: B4-T

value: Good Prognosis


title: B24-T


title: B1-T


title: B27-T


title: B5-T


title: B2-T


title: B23-T


title: B15-T


title: B14-T


title: B8-T


title: B95-T


title: B28-T


title: B18-T


title: B81-T


title: B10-T


title: B88-T


title: B29-T


title: B6-T


title: B109-T


title: B108-T


title: B99-T


title: B16-T


title: B12-T


title: B33-T


title: B7-T


title: B113-T


title: B93-T


title: B13-T


title: B94-T


title: B90-T


title: B87-T


title: B91-T


title: B92-T


title: B83-T


title: B111-T


title: B103-T


title: B79-T


title: B115-T


title: B82-T


title: B80-T


title: B78-T


title: B104-T


title: B97-T


title: B86-T


title: B105-T


title: B106-T


title: B50-T


title: B100-T

scan_protocol: = Standard Affymetrix protocol


title: brain, hippocampus: PH4_e1_le1

status: Public on Aug 05 2005

description:
Phenytoin hippocampus 4
Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.

source_name: brain, hippocampus


title: B46-T


title: B84-T


title: B73-T


title: B48-T


title: B107-T


title: B42-T


title: B112-T


title: B51-T


title: B75-T


title: B101-T


title: B49-T


title: B47-T


title: B70-T


title: B58-T


title: B89-T


title: B44-T


title: B53-T


title: B68-T


title: B85-T


title: B76-T


title: B45-T


title: B77-T


title: B98-T


title: B102-T


title: B74-T


title: B60-T


title: B67-T


title: B56-T


title: B62-T


title: B61-T


title: B72-T


title: B66-T


title: B63-T


title: B55-T


title: B43-T


title: B114-T


title: B54-T


title: B59-T


title: B71-T


title: B110-T


title: B57-T


title: brain, frontal cortex: Sample54_e1_le1

status: Public on Jul 06 2005

description:
Phenytoin frontal cortex 5
Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.

source_name: brain, frontal cortex


title: brain, frontal cortex: Sample60_e1_le1

description:
Control frontal cortex 5
Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample49_e1_le1

description:
Levitiracetam frontal cortex 7
Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: B52-T


title: brain, frontal cortex: Sample57_e1_le1

description:
Control frontal cortex 1
Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample46_e1_le1

description:
Levitiracetam frontal cortex 4
Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample45_e1_le1

description:
Levitiracetam frontal cortex 3
Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample52_e1_le1

description:
Phenytoin frontal cortex 3
Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample48_e1_le1

description:
Levitiracetam frontal cortex 6
Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample56_e1_le1

description:
Phenytoin frontal cortex 7
Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample44_e1_le1

description:
Levitiracetam frontal cortex 2
Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample58_e1_le1

description:
Control frontal cortex 2
Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample47_e1_le1

description:
Levitiracetam frontal cortex 5
Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.


title: brain, frontal cortex: Sample59_e1_le1

description:
Control frontal cortex 3
Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.